{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T04:22:52Z","timestamp":1768969372400,"version":"3.49.0"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2014,10,27]],"date-time":"2014-10-27T00:00:00Z","timestamp":1414368000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0109501","type":"journal-article","created":{"date-parts":[[2014,10,27]],"date-time":"2014-10-27T17:47:24Z","timestamp":1414432044000},"page":"e109501","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["All-Cause Mortality in Patients with Type 2 Diabetes in Association with Achieved Hemoglobin A1c, Systolic Blood Pressure, and Low-Density Lipoprotein Cholesterol Levels"],"prefix":"10.1371","volume":"9","author":[{"given":"Hou-Hsien","family":"Chiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen-Yu","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Ting","family":"See","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua-Fen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,10,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"RR Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Action to Control Cardiovascular Risk in Diabetes Study Group: Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"HC Gerstein","year":"2008","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"A Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"W Duckworth","year":"2009","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1006524","article-title":"Long-term effects of intensive glucose lowering on cardiovascular outcomes","volume":"364","author":"HC Gerstein","year":"2011","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0140-6736(09)61969-3","article-title":"Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study","volume":"375","author":"CJ Currie","year":"2010","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2337\/dc10-2377","article-title":"Glycemic control, complications, and death in older diabetic patients: the diabetes and aging study","volume":"34","author":"ES Huang","year":"2011","journal-title":"Diabetes Care"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2337\/dc10-1318","article-title":"A1C and cardiovascular outcomes in type 2 diabetes: a nested case-control study","volume":"34","author":"DC Colayco","year":"2011","journal-title":"Diabetes Care"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2796.2010.02265.x","article-title":"New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR)","volume":"268","author":"K Eeg-Olofsson","year":"2010","journal-title":"J Intern Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1001\/archinte.168.15.1699","article-title":"The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program","volume":"168","author":"HC Gerstein","year":"2008","journal-title":"Arch Intern Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"AV Chobanian","year":"2003","journal-title":"JAMA"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2337\/diacare.16.2.434","article-title":"Diabetes, other risk factors, and 12 yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial","volume":"16","author":"J Stamler","year":"1993","journal-title":"Diabetes Care"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/bmj.321.7258.412","article-title":"Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study","volume":"321","author":"AI Adler","year":"2000","journal-title":"BMJ"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38","volume":"317","year":"1998","journal-title":"BMJ"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial","volume":"351","author":"L Hansson","year":"1998","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/bmj.321.7258.412","article-title":"Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study","volume":"321","author":"AI Adler","year":"2000","journal-title":"BMJ"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc13-S011","article-title":"Standards of medical care in diabetes\u20142013","volume":"36","year":"2013","journal-title":"Diabetes Care"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"AV Chobanian","year":"2003","journal-title":"JAMA"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"ACCORD Study Group: Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"WC Cushman","year":"2010","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"CARDS investigators: Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomized placebo-controlled trial","volume":"364","author":"HM Colhoun","year":"2004","journal-title":"Lancet"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2337\/diacare.20.4.614","article-title":"Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)","volume":"20","author":"K Pyor\u00e4l\u00e4","year":"1997","journal-title":"Diabetes Care"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1161\/01.CIR.98.23.2513","article-title":"the Care Investigators: Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial","volume":"98","author":"RB Goldberg","year":"1998","journal-title":"Circulation"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(03)13636-7","article-title":"MRC\/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial","volume":"361","author":"R Collins","year":"2003","journal-title":"Lancet"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2337\/diacare.28.5.1151","article-title":"Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial\u2013lipid-lowering arm (ASCOT-LLA)","volume":"28","author":"PS Sever","year":"2005","journal-title":"Diabetes Care"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(08)60104-X","article-title":"Cholesterol Treatment Trialists&apos; (CTT) Collaborators: Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis","volume":"371","author":"PM Kearney","year":"2008","journal-title":"Lancet"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.2337\/dc05-2465","article-title":"Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study","volume":"29","author":"J Shepherd","year":"2006","journal-title":"Diabetes Care"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2337\/diacare.27.7.1605","article-title":"Mortality and causes of death in a national sample of diabetic patients in Taiwan","volume":"27","author":"CH Tseng","year":"2004","journal-title":"Diabetes Care"},{"key":"ref29","unstructured":"Bureau of National Health Insurance website. [<ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.nhi.gov.tw\/resource\/bulletin\/421_0890036465-19.doc\" xlink:type=\"simple\">http:\/\/www.nhi.gov.tw\/resource\/bulletin\/421_0890036465-19.doc<\/ext-link>] Accessed April 1, 2013."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1016\/j.jacc.2013.05.086","article-title":"Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction","volume":"62","author":"AE Epstein","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/jama.2012.216476","article-title":"Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia","volume":"309","author":"K Dharmarajan","year":"2013","journal-title":"JAMA"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000054810","article-title":"Trends in hospitalized stroke for blacks and whites in the United States, 1980\u20131999","volume":"21","author":"BS Kennedy","year":"2002","journal-title":"Neuroepidemiology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2337\/dc10-2006","article-title":"Risk of malignant neoplasm of the pancreas in relation to diabetes: a population-based study in Taiwan","volume":"34","author":"HF Chen","year":"2011","journal-title":"Diabetes Care"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1053\/j.ajkd.2012.03.018","article-title":"Risk of herpes zoster in CKD: a matched-cohort study based on administrative data","volume":"60","author":"MY Wu","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jfma.2012.09.013","article-title":"Mortality trends in patients with diabetes in Taiwan: a nationwide survey in 2000\u20132009","volume":"111","author":"HY Li","year":"2012","journal-title":"J Formos Med Assoc"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1464-5491.2010.03189.x","article-title":"Risk equations to predict life expectancy of people with Type 2 diabetes mellitus following major complications: a study from Western Australia","volume":"28","author":"AJ Hayes","year":"2011","journal-title":"Diabet Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1056\/NEJMoa1003795","article-title":"Severe hypoglycemia and risks of vascular events and death","volume":"363","author":"S Zoungas","year":"2010","journal-title":"N Engl J Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0140-6736(09)60697-8","article-title":"Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials","volume":"373","author":"KK Ray","year":"2009","journal-title":"Lancet"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2337\/dc10-0013","article-title":"Effects of acute insulin-induced hypoglycemia on indices of inflammation: putative mechanism for aggravating vascular disease in diabetes","volume":"33","author":"RJ Wright","year":"2010","journal-title":"Diabetes Care"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/jama.2010.884","article-title":"Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease","volume":"304","author":"RM Cooper-DeHoff","year":"2010","journal-title":"JAMA"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e5567","DOI":"10.1136\/bmj.e5567","article-title":"Association of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study","volume":"345","author":"EP Vamos","year":"2012","journal-title":"BMJ"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"PA James","year":"2014","journal-title":"JAMA"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"CP Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.292.11.1307","article-title":"Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial","volume":"292","author":"JA de Lemos","year":"2004","journal-title":"JAMA"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1111\/j.1532-5415.2005.00492.x","article-title":"Low-density lipoprotein cholesterol and mortality in older people","volume":"53","author":"V Tikhonoff","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1532-5415.2005.53106.x","article-title":"Relationship between plasma lipids and all-cause mortality in nondemented elderly","volume":"53","author":"N Schupf","year":"2005","journal-title":"J Am Geriatr Soc"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0109501","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T18:04:13Z","timestamp":1565978653000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0109501"}},"subtitle":[],"editor":[{"given":"Yan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,10,27]]},"references-count":46,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,10,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0109501","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,27]]}}}